Literature DB >> 12873746

Progressive increase in incidence and prevalence of multiple sclerosis in Newcastle, Australia: a 35-year study.

M H Barnett1, D B Williams, S Day, P Macaskill, J G McLeod.   

Abstract

The prevalence of multiple sclerosis (MS) in Newcastle, Australia increased significantly between 1961 and 1981 and the incidence of the disease also increased between the decades 1950-1959 and 1971-1981. The present study sought to determine whether there has been a further increase in the frequency of MS in the subsequent 15 years, and to examine the potential factors underlying this change. The incidence, prevalence and clinical profile of multiple sclerosis were therefore re-examined in Newcastle, Australia in 1996 using comparable diagnostic criteria and methods to those employed in studies in the same region in 1961 and 1981. There has been a significant progressive increase in prevalence from 19.6 to 59.1 per 100,000 population and a significant increase in incidence from 1.2 to 2.4 per 100,000 population from 1961 to 1996. The most pronounced increase in prevalence was in females and in the age-group over 60 years, and there was also an increased incidence in females aged 20-29 years. There was little change in the age of disease onset, but duration of disease in females had increased substantially. The significant increase in prevalence is attributed to increased incidence, particularly in females; and to increased survival. Although such trends in prevalence have been observed in the Northern Hemisphere, this is the first such study in the Southern Hemisphere to show a longitudinal increase in prevalence and incidence over a period of this duration.

Entities:  

Mesh:

Year:  2003        PMID: 12873746     DOI: 10.1016/s0022-510x(03)00122-9

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  15 in total

1.  Are the prevalence and incidence of multiple sclerosis changing?

Authors:  Julián Benito-León
Journal:  Neuroepidemiology       Date:  2011-04-20       Impact factor: 3.282

2.  Association of UV radiation with multiple sclerosis prevalence and sex ratio in France.

Authors:  S-M Orton; L Wald; C Confavreux; S Vukusic; J P Krohn; S V Ramagopalan; B M Herrera; A D Sadovnick; G C Ebers
Journal:  Neurology       Date:  2011-02-01       Impact factor: 9.910

Review 3.  Environmental factors and their timing in adult-onset multiple sclerosis.

Authors:  Adam E Handel; Gavin Giovannoni; George C Ebers; Sreeram V Ramagopalan
Journal:  Nat Rev Neurol       Date:  2010-02-16       Impact factor: 42.937

4.  Living with multiple sclerosis: longitudinal changes in employment and the importance of symptom management.

Authors:  Rex D Simmons; Kate L Tribe; Elizabeth A McDonald
Journal:  J Neurol       Date:  2010-01-19       Impact factor: 4.849

5.  Incidence of multiple sclerosis in the United Kingdom : findings from a population-based cohort.

Authors:  A Alonso; S S Jick; M J Olek; M A Hernán
Journal:  J Neurol       Date:  2007-10-01       Impact factor: 4.849

Review 6.  Temporal trends in the incidence of multiple sclerosis: a systematic review.

Authors:  Alvaro Alonso; Miguel A Hernán
Journal:  Neurology       Date:  2008-07-08       Impact factor: 9.910

Review 7.  The financial contribution of the multiple sclerosis specialist.

Authors:  Joseph R Berger
Journal:  Neurol Clin Pract       Date:  2017-06

8.  Geomagnetic disturbances may be environmental risk factor for multiple sclerosis: an ecological study of 111 locations in 24 countries.

Authors:  Seyed Aidin Sajedi; Fahimeh Abdollahi
Journal:  BMC Neurol       Date:  2012-09-24       Impact factor: 2.474

9.  Incidence of multiple sclerosis among European Economic Area populations, 1985-2009: the framework for monitoring.

Authors:  Enrique Alcalde-Cabero; Javier Almazán-Isla; Antonio García-Merino; Joao de Sá; Jesús de Pedro-Cuesta
Journal:  BMC Neurol       Date:  2013-06-12       Impact factor: 2.474

10.  The causal cascade to multiple sclerosis: a model for MS pathogenesis.

Authors:  Douglas S Goodin
Journal:  PLoS One       Date:  2009-02-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.